Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2009; Volume 195, Supplement 669
The 88th Annual Meeting of The German Physiological Society
3/22/2009-3/25/2009
Giessen, Germany


AZATHIOPRINE FAVORABLY INFLUENCES THE COURSE OF MALARIA
Abstract number: P443

Alesutan1 I., Bobbala1 D., Koka1 S., Geiger1 C., Foller1 M., Huber1 S., Lang1 F.

1Department of Physiology, Eberhard-Karls-University of Tuebingen, Tbingen

Azathioprine triggers suicidal erythrocyte death or eryptosis, characterized by cell shrinkage and exposure of phosphatidylserine at the erythrocyte surface. Eryptosis may accelerate clearance of Plasmodium-infected erythrocytes. The present study thus explored whether azathioprine influences eryptosis of Plasmodium-infected erythrocytes, development of parasitemia and thus the course of malaria. Phosphatidylserine-exposure was estimated from annexin V-binding and cell volume from forward scatter in FACS analysis. In vitro infection of human erythrocytes with P. falciparum increased annexin V-binding and initially decreased forward scatter, effects significantly augmented by azathioprine. At higher concentrations azathioprine significantly decreased intraerythrocytic DNA/RNA content and in vitro parasitemia. Subcutaneous administration of azathioprine (5 mg/kg b.w.) significantly decreased the parasitemia of circulating erythrocytes and increased the survival of P. berghei-infected mice (from 0% to 80% 22 days after infection). In conclusion, azathioprine enhances suicidal death of infected erythrocytes, decreases parasitemia and fosters host survival during malaria.

To cite this abstract, please use the following information:
Acta Physiologica 2009; Volume 195, Supplement 669 :P443

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE